시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
질염 치료제 시장 규모, 점유율, 성장 분석 : 질환별, 제품별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Vaginitis Therapeutics Market Size, Share, and Growth Analysis, By Disease (Anti-fungal, Anti-bacterial), By Product (Over-the-counter (OTC), Prescription), By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드 : 1663144
리서치사 : SkyQuest
발행일 : 2025년 02월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,909,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 9,252,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,595,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 질염 치료제 시장 규모는 2023년에 37억 달러로 평가되며, 2024년 39억 9,000만 달러에서 2032년에는 72억 7,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 7.8%로 성장할 전망입니다.

세계 질염 치료제 시장은 질 감염증의 유병률 증가에 따라 효과적인 치료에 대한 수요가 급증하고 있습니다. 주요 시장 동향은 항균제 및 프로바이오틱스에 대한 관심 증가와 함께 개인화된 저침습적 솔루션으로의 전환을 보여줍니다. 기술 발전은 혁신적인 제형과 진단 툴의 개발을 촉진하고 있습니다. 주요 기업은 연구에 적극적으로 투자하고 파트너십을 맺어 제품 라인업을 확장하고 있습니다. 북미와 유럽은 탄탄한 의료 인프라와 높은 인식으로 인해 현재 시장을 주도하고 있지만, 아시아태평양의 신흥 국가들은 의료 접근성 향상과 질 건강에 대한 인식이 높아지면서 큰 성장 기회를 제공합니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

질염 치료제 시장 규모 : 질환별 & CAGR(2025-2032)

질염 치료제 시장 규모 : 제품별 & CAGR(2025-2032)

질염 치료제 시장 규모 : 유통 채널별 & CAGR(2025-2032)

질염 치료제 시장 규모 : 지역별 & CAGR(2025-2032)

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Global Vaginitis Therapeutics Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 3.99 billion in 2024 to USD 7.27 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The global vaginitis therapeutics market is witnessing a surge in demand for effective treatments, driven by the increasing prevalence of vaginal infections. Key market trends reveal a shift toward personalized and minimally invasive solutions, with growing interest in antimicrobial agents and probiotics. Technological advancements are catalyzing the creation of innovative formulations and diagnostic tools. Major companies are actively investing in research and forming partnerships to broaden their product offerings. While North America and Europe currently dominate the market due to robust healthcare infrastructure and heightened awareness, emerging economies in the Asia-Pacific region present significant growth opportunities, spurred by enhancing healthcare access and rising awareness of vaginal health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vaginitis Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vaginitis Therapeutics Market Segments Analysis

Global Vaginitis Therapeutics Market is segmented by Disease, Product, Distribution Channel and region. Based on Disease, the market is segmented into Anti-fungal, Anti-bacterial and Hormone. Based on Product, the market is segmented into Over-the-counter (OTC) and Prescription. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Vaginitis Therapeutics Market

The global market for vaginitis therapeutics is primarily driven by the widespread occurrence of vaginitis, which encompasses several types of vaginal infections and inflammatory conditions affecting women globally. This high prevalence directly influences the demand for effective treatments. Contributing factors, such as inadequate hygiene, the use of specific contraceptive methods, antibiotic therapies, and fluctuations in hormonal levels, further exacerbate the incidence of vaginitis. As awareness of women's health issues grows and the need for effective remedies increases, the market for vaginitis therapeutics is expected to expand significantly in response to these compelling drivers.

Restraints in the Global Vaginitis Therapeutics Market

One of the significant restraints affecting the Global Vaginitis Therapeutics market is the widespread use of antibiotics for treating bacterial vaginosis, a common vaginitis condition. The over-prescription and inappropriate use of these antibiotics have contributed to the development of antibiotic-resistant bacterial strains. This resistance not only diminishes the effectiveness of standard antibiotic treatments but also complicates the overall management of bacterial vaginosis, potentially leading to increased healthcare costs and challenges in developing effective therapeutic strategies. As healthcare providers navigate this evolving landscape, the efficacy of existing treatments is being scrutinized, creating hurdles for market growth.

Market Trends of the Global Vaginitis Therapeutics Market

The Global Vaginitis Therapeutics market is witnessing a notable trend characterized by rising awareness and education surrounding vaginal health and infections. As more women become informed about their reproductive health issues, there is an increased demand for precise diagnosis, treatment, and prevention strategies for vaginitis. This heightened awareness is prompting a greater number of women to seek medical assistance promptly, which is expected to boost the demand for effective therapeutic solutions. Consequently, pharmaceutical companies are likely to focus on developing innovative treatments, further propelling market growth and advancements in the sector to cater to this growing consumer awareness.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Vaginitis Therapeutics Market Size by Disease & CAGR (2025-2032)

Global Vaginitis Therapeutics Market Size by Product & CAGR (2025-2032)

Global Vaginitis Therapeutics Market Size by Distribution Channel & CAGR (2025-2032)

Global Vaginitis Therapeutics Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기